Mark used for prediction of prognosis of lung adenocarcinoma

A lung adenocarcinoma and marker technology, which can be used in the determination/examination of microorganisms, biochemical equipment and methods, DNA/RNA fragments, etc., and can solve the problem of unclear diagnosis of lung adenocarcinoma.

Active Publication Date: 2019-04-16
NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV
View PDF9 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Although the above-mentioned patent discloses genes that can be used as markers of lung adenocarcinoma, the specification only records that t...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mark used for prediction of prognosis of lung adenocarcinoma
  • Mark used for prediction of prognosis of lung adenocarcinoma
  • Mark used for prediction of prognosis of lung adenocarcinoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] A set of markers used for prognosis prediction of lung adenocarcinoma, consisting of OPN3, GALNT2, FAM83A, KYNU, the prognosis prediction formula was confirmed according to the LASSO Cox regression model, and the prognosis prediction formula was: P=0.0004A+0.0042B+0.0055C+0.0077 D, where P is the risk coefficient, A is the expression of OPN3, B is the expression of GALNT2, C is the expression of FAM83A, and D is the expression of KYNU. When the risk coefficient is higher than 0.216, it is defined as high risk, otherwise is low risk.

Embodiment 2

[0032] The application of reagents for quantifying the expression levels of OPN3, GALNT2, FAM83A, and KYNU in the preparation of diagnostic reagents for lung adenocarcinoma. The prognostic prediction formula was confirmed according to the LASSO Cox regression model. The prognostic prediction formula was: P=0.0004A+0.0042B+0.0055C+0.0077 D, where P is the risk coefficient, A is the expression of OPN3, B is the expression of GALNT2, C is the expression of FAM83A, and D is the expression of KYNU. When the risk coefficient is higher than 0.216, it is defined as high risk, otherwise is low risk.

Embodiment 3

[0034] A lung adenocarcinoma prognosis prediction kit, the kit contains reagents for quantifying the expression levels of OPN3, GALNT2, FAM83A and KYNU, the prognosis prediction formula is confirmed according to the LASSO Cox regression model, and the prognosis prediction formula is: P=0.0004A+0.0042B +0.0055C+0.0077D, where P is the risk factor, A is the expression level of OPN3, B is the expression level of GALNT2, C is the expression level of FAM83A, and D is the expression level of KYNU, defined when the risk factor is higher than 0.216 high risk, otherwise low risk.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a mark used for prediction of prognosis of a lung adenocarcinoma. The mark is composed of OPN3, GALNT2, FAM83A AND KYUN, and a mathematical model for prediction of prognosis ofthe lung adenocarcinoma is established based on the four indexes of OPN3, GALNT2, FAM83A AND KYUN, wherein the expression formula of the mathematical model is P=0.0004A+0.0042B+0.0055C+0.0077D, in the formula, P is a risk coefficient, A is the expression quantity of OPN3, B is the expression quantity of GALANT2, C is the expression quantity of FAM83A, and D is the expression quantity of KYNU. When P is higher than 0.216, it is defined to have a high risk, and otherwise it is defined to have a low risk. The prediction for AUC of the prognosis of the lung adenocarcinoma reaches 0.71 through themodel, when cut-off is 0.216, the sensitiveness of predicting a three-year overall life cycle of a patient with the lung adenocarcinoma is 53.3% through the mode, specificity is 82.9%, the average overall life cycle of patient groups with high risks of the lung adenocarcinoma is about 46 months, and the average overall life cycle of patient groups with low risks is about 94 months.

Description

technical field [0001] The present invention relates to a marker for prognosis prediction of lung adenocarcinoma. Background technique [0002] Lung cancer is a disease that seriously endangers human health and life, and its morbidity and mortality have jumped to the top of cancer worldwide. In China, lung cancer is the malignant tumor with the fastest increasing morbidity and mortality, and has replaced liver cancer as the leading cause of death from malignant tumors. Adenocarcinoma is the most important histological type of lung cancer, accounting for more than 50% of all cases, and it is one of the focuses of lung cancer prevention and research. Like other malignant tumors, early detection, early diagnosis, and early treatment are the keys to reducing the mortality rate of lung adenocarcinoma. Lung adenocarcinomas mostly originate from smaller epithelial cells of bronchial mucosal secretions, and most adenocarcinomas are located around the lung tissue as spherical masse...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12Q1/6886C12N15/11
CPCC12Q1/6886C12Q2600/158C12Q2600/118
Inventor 卢笛王禾蔡开灿
Owner NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products